{"transactions":[{"id":730482,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2026-06-22T20:08:21.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":22371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted shares that vest in full on June 17, 2027, subject to the Reporting Person's continued service as a member of the issuer's board of directors through such vesting date."}],"balance_after":72787,"source":{"system":"sec-edgar","filing":"0000905148-26-003027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672709/000090514826003027/form4.xml","form_type":"4"}},{"id":786088,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-11T20:05:06.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":1265,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13977,"source":{"system":"sec-edgar","filing":"0001193125-26-216727","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/31791/000119312526216727/ownership.xml","form_type":"4"}},{"id":786087,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-11T20:05:06.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":1015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 27, 2027, the scheduled date for the issuer's next annual meeting of shareholders, subject to the Reporting Person's continued service through such date or, if earlier, upon the Reporting Person's death, disability or qualifying retirement, or the termination of the Reporting Person's service within 12 months following a change in control."}],"balance_after":12712,"source":{"system":"sec-edgar","filing":"0001193125-26-216727","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/31791/000119312526216727/ownership.xml","form_type":"4"}},{"id":1103791,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true}}],"security":"American Depositary Shares","published_at":"2025-06-23T20:11:46.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":10831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted shares that vest in full on June 18, 2026, subject to the Reporting Person's continued service as a member of the issuer's board of directors through such vesting date."}],"balance_after":50416,"source":{"system":"sec-edgar","filing":"0000905148-25-002220","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672709/000090514825002220/form4.xml","form_type":"4"}},{"id":1163174,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-01T20:05:23.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":1338,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11697,"source":{"system":"sec-edgar","filing":"0000950170-25-061826","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/31791/000095017025061826/ownership.xml","form_type":"4"}},{"id":1163173,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-01T20:05:23.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":1074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 28, 2026, the scheduled date for the issuer's next annual meeting of shareholders, subject to the Reporting Person's continued service through such date or, if earlier, upon the Reporting Person's death, disability or qualifying retirement, or the termination of the Reporting Person's service within 12 months following a change in control."}],"balance_after":10359,"source":{"system":"sec-edgar","filing":"0000950170-25-061826","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/31791/000095017025061826/ownership.xml","form_type":"4"}},{"id":1473190,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true}}],"security":"American Depositary Shares","published_at":"2024-06-20T21:01:00.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":21253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted shares that vest in full on June 18, 2025, subject to the Reporting Person's continued service as a member of the issuer's board of directors through such vesting date."}],"balance_after":39585,"source":{"system":"sec-edgar","filing":"0000905148-24-001751","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672709/000090514824001751/form4.xml","form_type":"4"}},{"id":1531509,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-02T20:05:25.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":1218,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9285,"source":{"system":"sec-edgar","filing":"0000950170-24-052069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/31791/000095017024052069/ownership.xml","form_type":"4"}},{"id":1531508,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-02T20:05:25.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock.  The grant of restricted stock units will fully vest on April 22, 2025, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control."}],"balance_after":8067,"source":{"system":"sec-edgar","filing":"0000950170-24-052069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/31791/000095017024052069/ownership.xml","form_type":"4"}},{"id":1890808,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T20:06:00.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":955,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7090,"source":{"system":"sec-edgar","filing":"0000950170-23-022714","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/31791/000095017023022714/ownership.xml","form_type":"4"}},{"id":1890807,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T20:06:00.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock.  The grant of restricted stock units will fully vest on April 23, 2024, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control."}],"balance_after":6135,"source":{"system":"sec-edgar","filing":"0000950170-23-022714","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/31791/000095017023022714/ownership.xml","form_type":"4"}},{"id":1965884,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2023-03-07T21:05:23.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":18332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":18332,"source":{"system":"sec-edgar","filing":"0000899243-23-007332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672709/000089924323007332/doc4.xml","form_type":"4"}},{"id":2278842,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-09T20:05:47.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":744,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5352,"source":{"system":"sec-edgar","filing":"0000899243-22-017248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/31791/000089924322017248/doc4.xml","form_type":"4"}},{"id":2278841,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-09T20:05:47.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 25, 2023, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control."}],"balance_after":4608,"source":{"system":"sec-edgar","filing":"0000899243-22-017248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/31791/000089924322017248/doc4.xml","form_type":"4"}},{"id":2380161,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:21:11.000Z","date":"2022-02-18","kind":"other","acquired":false,"shares":8909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":30210,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":8909},"source":{"system":"sec-edgar","filing":"0001127602-22-006280","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006280/form4.xml","form_type":"4"}},{"id":2380160,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:21:11.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":6191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":39119,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":6191},"source":{"system":"sec-edgar","filing":"0001127602-22-006280","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006280/form4.xml","form_type":"4"}},{"id":2380159,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-23T21:21:11.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":2746,"price":209.79,"value":576083.34,"ownership":{"direct":true},"balance_after":67261.188,"source":{"system":"sec-edgar","filing":"0001127602-22-006280","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006280/form4.xml","form_type":"4"}},{"id":2380158,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-23T21:21:11.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":6191,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70007.188,"source":{"system":"sec-edgar","filing":"0001127602-22-006280","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006280/form4.xml","form_type":"4"}},{"id":2395636,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:12:51.000Z","date":"2022-02-12","kind":"other","acquired":false,"shares":8163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":12564,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":8163},"source":{"system":"sec-edgar","filing":"0001127602-22-004986","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004986/form4.xml","form_type":"4"}},{"id":2395635,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:12:51.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":4395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":20727,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":4395},"source":{"system":"sec-edgar","filing":"0001127602-22-004986","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004986/form4.xml","form_type":"4"}},{"id":2395634,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:12:51.000Z","date":"2022-02-12","kind":"other","acquired":false,"shares":8205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":8205},"source":{"system":"sec-edgar","filing":"0001127602-22-004986","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004986/form4.xml","form_type":"4"}},{"id":2395633,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:12:51.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":4321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":8205,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":4321},"source":{"system":"sec-edgar","filing":"0001127602-22-004986","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004986/form4.xml","form_type":"4"}},{"id":2395632,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-15T21:12:51.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":4699,"price":214.59,"value":1008358.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy the withholding tax liability due upon vesting of shares, as previously disclosed by reporting person on January 21, 2022."}],"balance_after":63816.188,"source":{"system":"sec-edgar","filing":"0001127602-22-004986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004986/form4.xml","form_type":"4"}},{"id":2395631,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-15T21:12:51.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":1950,"price":214.59,"value":418450.5,"ownership":{"direct":true},"balance_after":68515.188,"source":{"system":"sec-edgar","filing":"0001127602-22-004986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004986/form4.xml","form_type":"4"}},{"id":2395630,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-15T21:12:51.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":4395,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70465.188,"source":{"system":"sec-edgar","filing":"0001127602-22-004986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004986/form4.xml","form_type":"4"}},{"id":2395629,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-15T21:12:51.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":1917,"price":214.59,"value":411369.03,"ownership":{"direct":true},"balance_after":66070.188,"source":{"system":"sec-edgar","filing":"0001127602-22-004986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004986/form4.xml","form_type":"4"}},{"id":2395628,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-15T21:12:51.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":4321,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":67987.188,"source":{"system":"sec-edgar","filing":"0001127602-22-004986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004986/form4.xml","form_type":"4"}},{"id":2399477,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-14T21:15:46.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":28405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":28405,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":28405},"source":{"system":"sec-edgar","filing":"0001127602-22-004775","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004775/form4.xml","form_type":"4"}},{"id":2429258,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-21T21:45:42.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":10594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2019.  The shares will vest on February 12, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 102.902 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2021."}],"balance_after":63666.188,"source":{"system":"sec-edgar","filing":"0001127602-22-001859","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222001859/form4.xml","form_type":"4"}},{"id":2722256,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-10T21:17:34.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":709,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3998,"source":{"system":"sec-edgar","filing":"0000899243-21-018993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/31791/000089924321018993/doc4.xml","form_type":"4"}},{"id":2722255,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-10T21:17:34.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock.  The grant of restricted stock units will fully vest on April 26, 2022, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control."}],"balance_after":3289,"source":{"system":"sec-edgar","filing":"0000899243-21-018993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/31791/000089924321018993/doc4.xml","form_type":"4"}},{"id":2844485,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-22T21:21:49.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":45310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":45310,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":45310},"source":{"system":"sec-edgar","filing":"0001127602-21-007011","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221007011/form4.xml","form_type":"4"}},{"id":2856367,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T22:03:06.000Z","date":"2021-02-12","kind":"other","acquired":false,"shares":7221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":25122,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":7221},"source":{"system":"sec-edgar","filing":"0001127602-21-006281","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006281/form4.xml","form_type":"4"}},{"id":2856366,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T22:03:06.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":5337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":32343,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":5337},"source":{"system":"sec-edgar","filing":"0001127602-21-006281","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006281/form4.xml","form_type":"4"}},{"id":2856365,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T22:03:06.000Z","date":"2021-02-12","kind":"other","acquired":false,"shares":7263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":12526,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":7263},"source":{"system":"sec-edgar","filing":"0001127602-21-006281","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006281/form4.xml","form_type":"4"}},{"id":2856364,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T22:03:06.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":5259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":19789,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":5259},"source":{"system":"sec-edgar","filing":"0001127602-21-006281","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006281/form4.xml","form_type":"4"}},{"id":2856363,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T22:03:06.000Z","date":"2021-02-12","kind":"other","acquired":false,"shares":6419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":6419},"source":{"system":"sec-edgar","filing":"0001127602-21-006281","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006281/form4.xml","form_type":"4"}},{"id":2856362,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T22:03:06.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":5693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":6419,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":5693},"source":{"system":"sec-edgar","filing":"0001127602-21-006281","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006281/form4.xml","form_type":"4"}},{"id":2856361,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T22:03:06.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":2367,"price":278.03,"value":658097.01,"ownership":{"direct":true},"balance_after":52969.286,"source":{"system":"sec-edgar","filing":"0001127602-21-006281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006281/form4.xml","form_type":"4"}},{"id":2856360,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T22:03:06.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":2333,"price":278.03,"value":648643.99,"ownership":{"direct":true},"balance_after":55336.286,"source":{"system":"sec-edgar","filing":"0001127602-21-006281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006281/form4.xml","form_type":"4"}},{"id":2856359,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T22:03:06.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":2525,"price":278.03,"value":702025.75,"ownership":{"direct":true},"balance_after":57669.286,"source":{"system":"sec-edgar","filing":"0001127602-21-006281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006281/form4.xml","form_type":"4"}},{"id":2856358,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T22:03:06.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":5337,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60194.286,"source":{"system":"sec-edgar","filing":"0001127602-21-006281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006281/form4.xml","form_type":"4"}},{"id":2856357,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T22:03:06.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":5259,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":54857.286,"source":{"system":"sec-edgar","filing":"0001127602-21-006281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006281/form4.xml","form_type":"4"}},{"id":2856356,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T22:03:06.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":5693,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49598.286,"source":{"system":"sec-edgar","filing":"0001127602-21-006281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006281/form4.xml","form_type":"4"}},{"id":2856355,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T22:03:06.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":7248,"price":278.03,"value":2015161.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy the withholding tax liability due upon the vesting of shares, as previously disclosed by reporting person on January 29, 2021."}],"balance_after":43905.286,"source":{"system":"sec-edgar","filing":"0001127602-21-006281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006281/form4.xml","form_type":"4"}},{"id":2891217,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-29T21:41:51.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":16343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2018.  The shares will vest on February 12, 2021."}],"balance_after":51153.286,"source":{"system":"sec-edgar","filing":"0001127602-21-002973","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221002973/form4.xml","form_type":"4"}},{"id":2963503,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-01T21:57:29.000Z","date":"2020-11-30","kind":"purchase","acquired":true,"shares":3100,"price":241.3054,"value":748046.74,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 84.965 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2020."}],"balance_after":34810.286,"source":{"system":"sec-edgar","filing":"0001127602-20-030238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220030238/form4.xml","form_type":"4"}},{"id":3153778,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-12T20:05:43.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":1081,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2685,"source":{"system":"sec-edgar","filing":"0000899243-20-012808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/31791/000089924320012808/doc4.xml","form_type":"4"}},{"id":3153777,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-12T20:05:43.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":244,"price":92.2,"value":22496.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock.  The grant of restricted stock units will fully vest on April 27, 2021, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units were awarded in lieu of the reporting person's first 2020 quarterly cash retainer payment, with the number of restricted stock units determined by dividing the amount of the cash retainer payment by the Black-Scholes value of a restricted stock unit on the date the grant was made."}],"balance_after":1604,"source":{"system":"sec-edgar","filing":"0000899243-20-012808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/31791/000089924320012808/doc4.xml","form_type":"4"}},{"id":3153776,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-12T20:05:43.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock.  The grant of restricted stock units will fully vest on April 27, 2021, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control."}],"balance_after":1360,"source":{"system":"sec-edgar","filing":"0000899243-20-012808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/31791/000089924320012808/doc4.xml","form_type":"4"}},{"id":3208024,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-17T20:05:17.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":438,"source":{"system":"sec-edgar","filing":"0000899243-20-008596","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/31791/000089924320008596/doc4.xml","form_type":"4"}},{"id":3208023,"issuer":{"id":3382,"kind":"organization","name":"REVVITY, INC.","symbol":"RVTY"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-17T20:05:17.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock.  The grant of restricted stock units will fully vest on March 16, 2021, which is the first anniversary of the date on which the grant was made."}],"balance_after":188,"source":{"system":"sec-edgar","filing":"0000899243-20-008596","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/31791/000089924320008596/doc4.xml","form_type":"4"}},{"id":3264787,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-19T23:20:59.000Z","date":"2020-02-15","kind":"other","acquired":false,"shares":3657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2020-02-15","underlying":"Common Stock","underlying_shares":3657},"source":{"system":"sec-edgar","filing":"0001127602-20-006552","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220006552/form4.xml","form_type":"4"}},{"id":3264786,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-19T23:20:59.000Z","date":"2020-02-15","kind":"exercise","acquired":false,"shares":4847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":3657,"derivative":{"exercise_price":0,"expiration_date":"2020-02-15","underlying":"Common Stock","underlying_shares":4847},"source":{"system":"sec-edgar","filing":"0001127602-20-006552","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220006552/form4.xml","form_type":"4"}},{"id":3264785,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-19T23:20:59.000Z","date":"2020-02-15","kind":"tax_withholding","acquired":false,"shares":2150,"price":333,"value":715950.0,"ownership":{"direct":true},"balance_after":31625.321,"source":{"system":"sec-edgar","filing":"0001127602-20-006552","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220006552/form4.xml","form_type":"4"}},{"id":3264784,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-19T23:20:59.000Z","date":"2020-02-15","kind":"exercise","acquired":true,"shares":4847,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33775.321,"source":{"system":"sec-edgar","filing":"0001127602-20-006552","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220006552/form4.xml","form_type":"4"}},{"id":3272111,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:19:07.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":37680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":37680,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":37680},"source":{"system":"sec-edgar","filing":"0001127602-20-005771","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005771/form4.xml","form_type":"4"}},{"id":3272110,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:19:07.000Z","date":"2020-02-12","kind":"other","acquired":false,"shares":6762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":25048,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":6762},"source":{"system":"sec-edgar","filing":"0001127602-20-005771","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005771/form4.xml","form_type":"4"}},{"id":3272109,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:19:07.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":5760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":31810,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":5760},"source":{"system":"sec-edgar","filing":"0001127602-20-005771","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005771/form4.xml","form_type":"4"}},{"id":3272108,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:19:07.000Z","date":"2020-02-12","kind":"other","acquired":false,"shares":5870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":12112,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":5870},"source":{"system":"sec-edgar","filing":"0001127602-20-005771","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005771/form4.xml","form_type":"4"}},{"id":3272107,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:19:07.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":6234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":17982,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":6234},"source":{"system":"sec-edgar","filing":"0001127602-20-005771","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005771/form4.xml","form_type":"4"}},{"id":3272106,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-14T23:19:07.000Z","date":"2020-02-12","kind":"tax_withholding","acquired":false,"shares":2555,"price":331.76,"value":847646.8,"ownership":{"direct":true},"balance_after":28928.321,"source":{"system":"sec-edgar","filing":"0001127602-20-005771","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005771/form4.xml","form_type":"4"}},{"id":3272105,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-14T23:19:07.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":5760,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31483.321,"source":{"system":"sec-edgar","filing":"0001127602-20-005771","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005771/form4.xml","form_type":"4"}},{"id":3272104,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-14T23:19:07.000Z","date":"2020-02-12","kind":"tax_withholding","acquired":false,"shares":2340,"price":331.76,"value":776318.4,"ownership":{"direct":true},"balance_after":25723.321,"source":{"system":"sec-edgar","filing":"0001127602-20-005771","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005771/form4.xml","form_type":"4"}},{"id":3272103,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-14T23:19:07.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":6234,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28063.321,"source":{"system":"sec-edgar","filing":"0001127602-20-005771","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005771/form4.xml","form_type":"4"}},{"id":3538486,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-05-06T20:20:38.000Z","date":"2019-05-02","kind":"other","acquired":false,"shares":1772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2019-05-02","underlying":"Common Stock","underlying_shares":1772},"source":{"system":"sec-edgar","filing":"0001127602-19-017441","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219017441/form4.xml","form_type":"4"}},{"id":3538485,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-05-06T20:20:38.000Z","date":"2019-05-02","kind":"exercise","acquired":false,"shares":1480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":1772,"derivative":{"exercise_price":0,"expiration_date":"2019-05-02","underlying":"Common Stock","underlying_shares":1480},"source":{"system":"sec-edgar","filing":"0001127602-19-017441","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219017441/form4.xml","form_type":"4"}},{"id":3538484,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-05-06T20:20:38.000Z","date":"2019-05-02","kind":"tax_withholding","acquired":false,"shares":658,"price":230.52,"value":151682.16,"ownership":{"direct":true},"balance_after":21829.321,"source":{"system":"sec-edgar","filing":"0001127602-19-017441","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219017441/form4.xml","form_type":"4"}},{"id":3538483,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-05-06T20:20:38.000Z","date":"2019-05-02","kind":"exercise","acquired":true,"shares":1480,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22487.321,"source":{"system":"sec-edgar","filing":"0001127602-19-017441","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219017441/form4.xml","form_type":"4"}},{"id":3543154,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-05-02T20:30:28.000Z","date":"2019-05-01","kind":"purchase","acquired":true,"shares":4351,"price":231.48,"value":1007169.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This represents the weighted average price for shares purchased at a range between $231.47 (low) and $232.06 (high)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Full information regarding the number of shares purchased at each separate price will be provided to the SEC staff, the issuer or any security holder of the issuer, upon their request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 82.051 shares acquired under the Biogen Inc. employee stock purchase plan on 3/29/2019."}],"balance_after":21007.321,"source":{"system":"sec-edgar","filing":"0001127602-19-016956","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219016956/form4.xml","form_type":"4"}},{"id":3647600,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-02-20T23:10:24.000Z","date":"2019-02-15","kind":"other","acquired":false,"shares":3229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":8504,"derivative":{"exercise_price":0,"expiration_date":"2020-02-15","underlying":"Common Stock","underlying_shares":3229},"source":{"system":"sec-edgar","filing":"0001127602-19-007262","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219007262/form4.xml","form_type":"4"}},{"id":3647599,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-02-20T23:10:24.000Z","date":"2019-02-15","kind":"exercise","acquired":false,"shares":5269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":11733,"derivative":{"exercise_price":0,"expiration_date":"2020-02-15","underlying":"Common Stock","underlying_shares":5269},"source":{"system":"sec-edgar","filing":"0001127602-19-007262","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219007262/form4.xml","form_type":"4"}},{"id":3647598,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-02-20T23:10:24.000Z","date":"2019-02-15","kind":"tax_withholding","acquired":false,"shares":2340,"price":332.87,"value":778915.8,"ownership":{"direct":true},"balance_after":16574.27,"source":{"system":"sec-edgar","filing":"0001127602-19-007262","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219007262/form4.xml","form_type":"4"}},{"id":3647597,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-02-20T23:10:24.000Z","date":"2019-02-15","kind":"exercise","acquired":true,"shares":5269,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18914.27,"source":{"system":"sec-edgar","filing":"0001127602-19-007262","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219007262/form4.xml","form_type":"4"}},{"id":3658398,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-02-14T23:33:56.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":37570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":37570,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":37570},"source":{"system":"sec-edgar","filing":"0001127602-19-006101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219006101/form4.xml","form_type":"4"}},{"id":3658397,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-02-14T23:33:56.000Z","date":"2019-02-12","kind":"other","acquired":false,"shares":5205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":24216,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":5205},"source":{"system":"sec-edgar","filing":"0001127602-19-006101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219006101/form4.xml","form_type":"4"}},{"id":3658396,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-02-14T23:33:56.000Z","date":"2019-02-12","kind":"exercise","acquired":false,"shares":6899,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":29421,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":6899},"source":{"system":"sec-edgar","filing":"0001127602-19-006101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219006101/form4.xml","form_type":"4"}},{"id":3658395,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-02-14T23:33:56.000Z","date":"2019-02-12","kind":"tax_withholding","acquired":false,"shares":2622,"price":319.43,"value":837545.46,"ownership":{"direct":true},"balance_after":13645.27,"source":{"system":"sec-edgar","filing":"0001127602-19-006101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219006101/form4.xml","form_type":"4"}},{"id":3658394,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-02-14T23:33:56.000Z","date":"2019-02-12","kind":"exercise","acquired":true,"shares":6899,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16267.27,"source":{"system":"sec-edgar","filing":"0001127602-19-006101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219006101/form4.xml","form_type":"4"}},{"id":3946135,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-05-04T22:09:38.000Z","date":"2018-05-02","kind":"other","acquired":false,"shares":1557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."}],"balance_after":3252,"derivative":{"exercise_price":0,"expiration_date":"2019-05-02","underlying":"Common Stock","underlying_shares":1557},"source":{"system":"sec-edgar","filing":"0001127602-18-016415","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218016415/form4.xml","form_type":"4"}},{"id":3946134,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-05-04T22:09:38.000Z","date":"2018-05-02","kind":"exercise","acquired":false,"shares":1687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":4809,"derivative":{"exercise_price":0,"expiration_date":"2019-05-02","underlying":"Common Stock","underlying_shares":1687},"source":{"system":"sec-edgar","filing":"0001127602-18-016415","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218016415/form4.xml","form_type":"4"}},{"id":3946133,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-04T22:09:38.000Z","date":"2018-05-02","kind":"tax_withholding","acquired":false,"shares":750,"price":274.13,"value":205597.5,"ownership":{"direct":true},"balance_after":9368.27,"source":{"system":"sec-edgar","filing":"0001127602-18-016415","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218016415/form4.xml","form_type":"4"}},{"id":3946132,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-04T22:09:38.000Z","date":"2018-05-02","kind":"exercise","acquired":true,"shares":1687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 74.812 shares acquired under the Biogen Inc. employee stock purchase plan on 3/29/2018."}],"balance_after":10118.27,"source":{"system":"sec-edgar","filing":"0001127602-18-016415","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218016415/form4.xml","form_type":"4"}},{"id":4049467,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-02-20T21:27:02.000Z","date":"2018-02-15","kind":"other","acquired":false,"shares":3144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":17002,"derivative":{"exercise_price":0,"expiration_date":"2020-02-15","underlying":"Common Stock","underlying_shares":3144},"source":{"system":"sec-edgar","filing":"0001127602-18-007215","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218007215/form4.xml","form_type":"4"}},{"id":4049466,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-02-20T21:27:02.000Z","date":"2018-02-15","kind":"exercise","acquired":false,"shares":5354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":20146,"derivative":{"exercise_price":0,"expiration_date":"2020-02-15","underlying":"Common Stock","underlying_shares":5354},"source":{"system":"sec-edgar","filing":"0001127602-18-007215","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218007215/form4.xml","form_type":"4"}},{"id":4049465,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-02-20T21:27:02.000Z","date":"2018-02-15","kind":"tax_withholding","acquired":false,"shares":1877,"price":299.38,"value":561936.26,"ownership":{"direct":true},"balance_after":8356.458,"source":{"system":"sec-edgar","filing":"0001127602-18-007215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218007215/form4.xml","form_type":"4"}},{"id":4049464,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-02-20T21:27:02.000Z","date":"2018-02-15","kind":"exercise","acquired":true,"shares":5354,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10233.458,"source":{"system":"sec-edgar","filing":"0001127602-18-007215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218007215/form4.xml","form_type":"4"}},{"id":4060773,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-02-14T23:38:44.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":36320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":36320,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":36320},"source":{"system":"sec-edgar","filing":"0001127602-18-006182","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218006182/form4.xml","form_type":"4"}},{"id":4118171,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-01-02T21:21:54.000Z","date":"2017-12-29","kind":"purchase","acquired":true,"shares":780,"price":320.55,"value":250029.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Purchase pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":4879.458,"source":{"system":"sec-edgar","filing":"0001127602-18-000128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218000128/form4.xml","form_type":"4"}},{"id":4334106,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-05-04T20:16:01.000Z","date":"2017-05-02","kind":"other","acquired":false,"shares":1508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":6496,"derivative":{"exercise_price":0,"expiration_date":"2019-05-02","underlying":"Common Stock","underlying_shares":1508},"source":{"system":"sec-edgar","filing":"0001127602-17-016857","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217016857/form4.xml","form_type":"4"}},{"id":4334105,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-05-04T20:16:01.000Z","date":"2017-05-02","kind":"exercise","acquired":false,"shares":1736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award was previously reported as covering 9,520 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ, Inc. on February 1, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This award was previously reported as covering 9,520 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ, Inc. on February 1, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This award was previously reported as covering 9,520 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ, Inc. on February 1, 2017."}],"balance_after":8004,"derivative":{"exercise_price":0,"expiration_date":"2019-05-02","underlying":"Common Stock","underlying_shares":1736},"source":{"system":"sec-edgar","filing":"0001127602-17-016857","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217016857/form4.xml","form_type":"4"}},{"id":4334104,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-04T20:16:01.000Z","date":"2017-05-02","kind":"tax_withholding","acquired":false,"shares":564,"price":271.34,"value":153035.76,"ownership":{"direct":true},"balance_after":4099.458,"source":{"system":"sec-edgar","filing":"0001127602-17-016857","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217016857/form4.xml","form_type":"4"}},{"id":4334103,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-04T20:16:01.000Z","date":"2017-05-02","kind":"exercise","acquired":true,"shares":1736,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4663.458,"source":{"system":"sec-edgar","filing":"0001127602-17-016857","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217016857/form4.xml","form_type":"4"}},{"id":4338953,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-02T20:18:26.000Z","date":"2017-05-01","kind":"purchase","acquired":true,"shares":1402,"price":271.35,"value":380432.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Purchase pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 91.527 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2017."}],"balance_after":2927.458,"source":{"system":"sec-edgar","filing":"0001127602-17-016342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217016342/form4.xml","form_type":"4"}},{"id":4415627,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-01T21:18:57.000Z","date":"2017-02-27","kind":"purchase","acquired":true,"shares":1333,"price":285.39,"value":380424.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Purchase pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 100.9310 shares acquired under the Biogen Inc. employee stock purchase plan on 09/30/16 and 12/30/16."}],"balance_after":1433.931,"source":{"system":"sec-edgar","filing":"0001127602-17-009254","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009254/form4.xml","form_type":"4"}},{"id":4440899,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":36332,"kind":"person","name":"Vounatsos Michel","position":1,"cik":"0001672709","reported_name":"Vounatsos Michel","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-02-18T01:30:02.000Z","date":"2017-02-15","kind":"grant","acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":25500,"derivative":{"exercise_price":0,"expiration_date":"2020-02-15","underlying":"Common Stock","underlying_shares":25500},"source":{"system":"sec-edgar","filing":"0001127602-17-007116","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217007116/form4.xml","form_type":"4"}}]}